N-Methyl-3-cyclopentene-1-methanamine | 1184955-37-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-Methyl-3-cyclopentene-1-methanamine
• 英文别名: 1-cyclopent-3-en-1-yl-N-methylmethanamine
• CAS: 1184955-37-0
• 化学式: C₇H₁₃N
• 分子量: 111.18
• InChiKey: IUEQKZIWEZDIOE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] METATHESIS CATALYSTS CONTAINING ONIUM GROUPS<br/>[FR] CATALYSEURS DE MÉTATHÈSE CONTENANT DES GROUPES ONIUM
  申请人：APEIRON SYNTHESIS SP Z O O

  公开号：WO2013127880A1

  公开（公告）日：2013-09-06

  Disclosed herein is a general method for the preparation of complexes containing a quaternary onium group in an inert ligand. Some of these complexes may be represented by formula (1): Methods for the preparation of complexes of formula 1, the preparation of intermediates and the use of complexes of formula 1 in metathesis reactions and a method for conducting an olefin metathesis reaction are also described.

  本文揭示了一种制备含有季铵基团的复合物的一般方法，其中该季铵基团位于惰性配体中。其中一些复合物可以由式（1）表示：还描述了制备式1复合物、制备中间体以及在交换反应中使用式1复合物的方法，以及进行烯烃交换反应的方法。
• NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
  申请人：MANOHARAN Muthiah

  公开号：US20120095075A1

  公开（公告）日：2012-04-19

  The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention provides lipids having the following structure:

  本发明提供了有利于用于体内向细胞传递治疗剂的脂质。具体而言，本发明提供具有以下结构的脂质：
• Lipids and compositions for the delivery of therapeutics
  申请人：Arbutus Biopharma Corporation

  公开号：US10835612B2

  公开（公告）日：2020-11-17

  The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention provides lipids having the following structures:

  本发明提供的脂质可用于脂质微粒中，有利于向细胞体内输送治疗剂。本发明尤其提供具有以下结构的脂质：
• OXYGEN SCAVENGERS WITH REDUCED OXIDATION PRODUCTS FOR USE IN PLASTIC FILMS AND BEVERAGE AND FOOD CONTAINERS
  申请人：CHEVRON PHILLIPS CHEMICAL COMPANY LP

  公开号：EP1066337A2

  公开（公告）日：2001-01-10
• ETHYNYL-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS
  申请人：Kwong Cecil D.

  公开号：US20120107271A1

  公开（公告）日：2012-05-03

  The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and pro-drugs of said compounds, wherein each of R, R 1 , X, Y, Z, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 18 , R 19 and n is selected independently and as defined herein. Compositions comprising such compounds are also provided. The compounds of the invention are effective as inhibitors of HCV, and are useful, alone and together with other therapeutic agents, in treating or preventing diseases or disorders such as viral infections and virus-related disorders.